Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
1086 participants
INTERVENTIONAL
2016-01-17
2020-01-16
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical Evaluation of Effectiveness of the "Therm'Up" Heating Device
NCT06788925
Hypothermia in the Trauma Patient - When do Trauma Patients Get Cold?
NCT01006837
Warm-up Efficiency by Body Warmer Versus Standard Procedure in Severely Traumatized Patients
NCT03970915
Assessment of the Benefit of an Inclusive Health Organization on the Prognosis of Severe Trauma Patients
NCT04275791
Accuracy of Non-invasive Temperature Measurement in Deep Hypothermia
NCT02009059
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Hypothermia is responsible, with acidosis and coagulopathy, of the " lethal triad" of trauma.
Thus, it is clearly established that hypothermia is directly associated with poor prognostic in trauma patients. In a recent study, mortality rate reached 100% for trauma patients arriving at the hospital with a body temperature below 32°C.
The weather, the severity of the trauma and medical (or paramedical) interventions are responsible for the onset of this hypothermia.
Then, continuous monitoring of the patient's temperature, active protection against hypothermia with a metal blanket, the warming (and measure the temperature of) infusion fluids, the warming (and measure the temperature of) the ambulance should improve patient's outcome. As hypothermia is associated with mortality of trauma patients, the control must lead to reduce mortality.
Randomization Due to the use of a global management strategy with combination of several specific interventions and the need for special equipment (heating devices infusion fluids), randomization will be done by investigator center: interventional center (combining the different interventions) and standard management (without modification, except measurements of the patient's and air temperature at inclusion and on arrival at a receiving center.
In this context, it is also crucial that the weather conditions, the characteristics of trauma and patients were similar in both groups. Also, 12 investigation centers will be classified based on annual local average temperatures.
Main collected data Demographics and morphological traits (age, sex, body weight, and height of the victim), the nature and circumstances of the accident (date, time, place), the victim's presentation on mobile intensive care unit (MICU) arrival (trapped or not, seated or lying down, on the ground, unclothed, wet, or covered by a blanket, environmental conditions, clinical factors, and care provided.
Environmental conditions included air (indoors or outdoors) temperature, and rain at the site of the accident as well as mobile intensive care unit temperature.
Clinical factors included: the site and nature of the lesions (fracture, wound, contusion), heart rate, the Revised Trauma Score (RTS) (Glasgow Coma Score (GCS) + systolic blood pressure + respiratory rate), oxygen saturation or oxygen delivery, and tympanic temperature.
Whenever applicable: vascular filling (infusion fluid temperature and volumes), catecholamine and morphine administration, any other drugs (with doses), orotracheal intubation.
Times from the accident to MICU arrival and from MICU arrival to hospital admission.
Statistical analysis Primary endpoint: rate of patients arriving at the hospital with a temperature \<35°C. These data will be analyzed by model of multi-level logistic regression to again consider the cluster design of the study. A secondary analysis will enter the model known a priori factors that may affect hypothermia. The parameters corresponding to the secondary objectives will be entered in a model of logistic regression multivariate thereby specifically test their effect on the criteria studied.
Secondary endpoints: Binary secondary endpoints will be analyzed by model of multi-level logistic regression. Quantitative secondary endpoints will be analyzed by mixed model ANCOVA introducing randomness in the center. The variables may be processed before analysis for non-Gaussian distribution. In case of failure of the normalizing transformation, exact procedure may be used.
Number of patients to include The calculation of the sample size was based on our previous study.\* The incidence of hypothermia on arrival at the hospital was 14%. By selecting high-risk patients, the investigators expect an incidence of about 20%. The objective is to achieve a reduction of one third of hypothermia (i.e. from 20 to 13 %). Using a two-tailed test at α risk of 0.05 and 1 - beta 0.8, the calculation of required number of patients is 440 per group. Assuming a moderate inflation factor of about 1.35 related to the cluster randomization (our experience shows that intra-cluster correlation coefficients are low) the total number of patients per group will be 600 patients.
A total of N = 1,200 patients for the study.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1: control group
Classic - current management of trauma patients by French medical teams
1: control group
Classic - current management of trauma patients by French medical teams
2: interventional group
Intervention Name : monitoring, treatment, control and prevention of hypothermia
* Continuous monitoring of body temperature
* Ambulance warming (target : 30°C)
* Patient warming with dedicated blanket
* Infusion fluid warming (and temperature control)
2: interventional group
Intervention Name : monitoring, treatment, control and prevention of hypothermia
* Continuous monitoring of body temperature
* Ambulance warming (target : 30°C)
* Patient warming with dedicated blanket
* Infusion fluid warming (and temperature control)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
1: control group
Classic - current management of trauma patients by French medical teams
2: interventional group
Intervention Name : monitoring, treatment, control and prevention of hypothermia
* Continuous monitoring of body temperature
* Ambulance warming (target : 30°C)
* Patient warming with dedicated blanket
* Infusion fluid warming (and temperature control)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Pre-hospital management by MICU
* Scheduled transfer to a receiving center by a MICU
* And at least one of the following criteria :
* Ambient temperature on the field \< 18°C
* Body temperature \<35°C on MICU arrival
* A Glasgow score \< 15 on MICU arrival
* Systolic blood pressure \< 100 mm Hg on MICU arrival
Exclusion Criteria
* Cardiac arrest before MICU arrival
* Bilateral ear bleeding preventing continuous monitoring of tympanic temperature
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assistance Publique - Hôpitaux de Paris
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Frédéric LAPOSTOLLE, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Assistance Publique - Hôpitaux de Paris
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
SAMU 93, AP-HP, Urgences - SAMU 93, Unité Recherche-Enseignement-Qualité, Hôpital Avicenne
Bobigny, , France
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Lapostolle F, Sebbah JL, Couvreur J, Koch FX, Savary D, Tazarourte K, Egman G, Mzabi L, Galinski M, Adnet F. Risk factors for onset of hypothermia in trauma victims: the HypoTraum study. Crit Care. 2012 Jul 31;16(4):R142. doi: 10.1186/cc11449.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2014-A00564-43
Identifier Type: OTHER
Identifier Source: secondary_id
131204
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.